Clinical Trial

Identifying Biomarkers for Endothelial Dysfunction in Women With Preeclampsia

Study acronym: DAISY
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 24, 2025 (before its estimated November 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Every pregnancy has a major impact on a woman's heart and blood vessels due to changes required by the body to maintain proper blood flow between mother and foetus. When the placenta does not work properly, preeclampsia can occur. An important first symptom is high blood pressure. Women who have experienced preeclampsia are at higher risk of developing blood pressure and heart problems later on. Therefore, it is very important to detect changes in the blood vessel system so that they can be treated promptly and correctly. We aim to do this by using a new, non-invasive eye test that examines the blood vessels of the retina.
Trial Details
NCT Number NCT07084727
Lead Sponsor University Hospital, Antwerp
Conditions Endothelial Function (FMD), Preeclampsia, Retinal Vessels
Enrollment 60 participants
Start Date 2025-07-01
Primary Completion 2025-11-15 (estimated)
Study Completion 2025-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-07-24